| ID | 253 |
|---|
| No | 253 |
|---|
| Brand Name | PEMIDX |
|---|
| Ingredients | PEMIGATINIB 4.5 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 28 TABLET'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | IN ADULT WHO HAVE ALREADY RECEIVED A PREVIOUS TREATMENT TO TREAT A CERTAIN TYPE OF CHOLANGIOCARCINOMA (BILE DUCT CANCER) THAT HAS SPREAD TO NEARBY TISSUES OR OTHER PARTS OF THE BODY AND CANNOT BE REMOVED BY SURGERY |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | ROUND TABLET, HAVING DX ON ONE SIDE AND 4.5 ON THE OTHER SIDE |
|---|
| Note | |
|---|
| License Owner | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Manufacturer | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 10 L 1023/23 |
|---|
| FDD Registration Date | 10/10/2023 |
|---|
| Expiry Date | 09/10/2026 |
|---|
